Effectiveness of a management program for outpatient clinic or remote titration of beta-blockers in CRT patients: The RESTORE study.

[1]  W. Alexander.  American College of Cardiology. , 2018, P & T : a peer-reviewed journal for formulary management.

[2]  C. Leclercq,et al.  Avoiding non-responders to cardiac resynchronization therapy: a practical guide , 2016, European heart journal.

[3]  A. Capucci,et al.  Association between remote implantable cardioverter defibrillator monitoring and beta-blocker utilization: An analysis from the EFFECT study , 2016, Journal of telemedicine and telecare.

[4]  J. Skinner,et al.  Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation. , 2016, Journal of the American College of Cardiology.

[5]  A. Capucci,et al.  Remote monitoring improves outcome after ICD implantation: the clinical efficacy in the management of heart failure (EFFECT) study. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  L. Calò,et al.  Evaluation of Synergistic Effects of Resynchronization Therapy and a β‐Blocker Up‐titration Strategy Based on a Predefined Patient‐Management Program: The RESTORE Study , 2015, Clinical cardiology.

[7]  P. Ponikowski,et al.  Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long‐Term Registry , 2013, European journal of heart failure.

[8]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[9]  Maurizio Marzegalli,et al.  Remote Monitoring Reduces Healthcare Use and Improves Quality of Care in Heart Failure Patients With Implantable Defibrillators: The Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators (EVOLVO) Study , 2012, Circulation.

[10]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[11]  A. Gavazzi,et al.  CArdiac resynchronization in combination with beta blocker treatment in advanced chronic heart failure (CARIBE-HF): the results of the CARIBE-HF study. , 2011, Acta cardiologica.

[12]  P. Heidenreich,et al.  Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study , 2010, Circulation.

[13]  C. O'connor,et al.  Comparison of Medical Therapy Dosing in Outpatients Cared for in Cardiology Practices With Heart Failure and Reduced Ejection Fraction With and Without Device Therapy: Report From IMPROVE HF , 2010, Circulation. Heart failure.

[14]  G. Fonarow,et al.  Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) , 2010, Circulation.

[15]  T. Burroughs,et al.  Underutilization of β-Blockers in Patients Undergoing Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Procedures , 2010, Circulation. Cardiovascular quality and outcomes.

[16]  A. de Silvestri,et al.  A meta-analysis of remote monitoring of heart failure patients. , 2009, Journal of the American College of Cardiology.

[17]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.

[18]  S. Najjar,et al.  Rapid titration of carvedilol in patients with congestive heart failure: a randomized trial of automated telemedicine versus frequent outpatient clinic visits. , 2006, American heart journal.

[19]  J. Conti,et al.  Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration. , 2005, The American journal of cardiology.

[20]  J. Daubert,et al.  Baseline characteristics of patients recruited into the CARE‐HF study , 2005, European journal of heart failure.

[21]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[22]  Randall E. Williams,et al.  Remote titration of carvedilol for heart failure patients by advanced practice nurses. , 2004, Journal of cardiac failure.

[23]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[24]  B. Fagerberg,et al.  How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). , 2003, Cardiac electrophysiology review.

[25]  Paul A. Heidenreich,et al.  Improving Guideline Adherence: A Randomized Trial Evaluating Strategies to Increase &bgr;-Blocker Use in Heart Failure , 2003, Circulation.

[26]  J. Rouleau,et al.  Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. , 2003, JAMA.

[27]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[28]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[29]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.